ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04724	Glutamatergic synapse	28/265	152/7206	8.26284024637e-13
ko05033	Nicotine addiction	17/265	56/7206	6.68143863536e-12
ko04728	Dopaminergic synapse	27/265	185/7206	5.7678960917e-10
ko04727	GABAergic synapse	20/265	110/7206	2.2541117702e-09
ko04721	Synaptic vesicle cycle	17/265	80/7206	3.12270814252e-09
ko04723	Retrograde endocannabinoid signaling	23/265	175/7206	8.69477275051e-08
ko04911	Insulin secretion	18/265	117/7206	2.1393519109e-07
ko05032	Morphine addiction	17/265	110/7206	4.39331844911e-07
ko04713	Circadian entrainment	19/265	136/7206	4.62374767395e-07
ko04080	Neuroactive ligand-receptor interaction	36/265	423/7206	1.70376698738e-06
ko04514	Cell adhesion molecules (CAMs)	17/265	130/7206	4.78016622263e-06
ko04261	Adrenergic signaling in cardiomyocytes	22/265	205/7206	5.4903054991e-06
ko04024	cAMP signaling pathway	25/265	279/7206	3.02858576441e-05
ko05030	Cocaine addiction	11/265	73/7206	6.34080558418e-05
ko05031	Amphetamine addiction	12/265	91/7206	0.000112711171731
ko04726	Serotonergic synapse	15/265	137/7206	0.000141428782233
ko04010	MAPK signaling pathway	25/265	321/7206	0.000352763373364
ko04022	cGMP-PKG signaling pathway	19/265	216/7206	0.000353939140012
ko05203	Viral carcinogenesis	1/265	277/7206	0.000505415591887
ko00512	Mucin type O-glycan biosynthesis	6/265	29/7206	0.000543673570564
ko04970	Salivary secretion	11/265	95/7206	0.000680302820627
ko04725	Cholinergic synapse	15/265	160/7206	0.000765324635728
ko04020	Calcium signaling pathway	21/265	265/7206	0.00117635957937
ko04666	Fc gamma R-mediated phagocytosis	12/265	122/7206	0.00168732302123
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	9/265	79/7206	0.00232084440701
ko04915	Estrogen signaling pathway	12/265	131/7206	0.00307882969339
ko04260	Cardiac muscle contraction	10/265	98/7206	0.00308580513666
ko04973	Carbohydrate digestion and absorption	6/265	42/7206	0.00402508749942
ko04742	Taste transduction	7/265	61/7206	0.00671497059505
ko04730	Long-term depression	8/265	78/7206	0.00760766954008
ko04720	Long-term potentiation	9/265	99/7206	0.0103412704524
ko04921	Oxytocin signaling pathway	15/265	209/7206	0.0131991003413
ko04924	Renin secretion	8/265	86/7206	0.0134001671499
ko04930	Type II diabetes mellitus	6/265	54/7206	0.0137468098153
ko00513	Various types of N-glycan biosynthesis	5/265	42/7206	0.0181248182122
ko04072	Phospholipase D signaling pathway	14/265	197/7206	0.0184997774698
ko05014	Amyotrophic lateral sclerosis (ALS)	7/265	74/7206	0.0185362451371
ko04360	Axon guidance	16/265	233/7206	0.0190593206103
ko04962	Vasopressin-regulated water reabsorption	6/265	58/7206	0.0190855292711
ko04972	Pancreatic secretion	9/265	111/7206	0.0206739269231
ko04014	Ras signaling pathway	18/265	279/7206	0.0211342831145
ko05213	Endometrial cancer	6/265	62/7206	0.0256904976081
ko05410	Hypertrophic cardiomyopathy (HCM)	8/265	100/7206	0.0303922420036
ko04621	NOD-like receptor signaling pathway	1/265	157/7206	0.0313527958913
ko05231	Choline metabolism in cancer	10/265	134/7206	0.0317859694189
ko04144	Endocytosis	20/265	342/7206	0.0378244506765
ko04371	Apelin signaling pathway	12/265	177/7206	0.0392992388559